Issue 12 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

32

No.

12

December 25, 2009Dec 25, 2009

Free

DOWNLOAD THE PDF

ASCO Annual Report Names Significant Clinical Research Advances Of Past Year

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

Tykerb Plus Herceptin Better Than Monotherapy, Study Says

Bisphosphonates May Reduce Recurrent Breast Cancer

Study Finds High-Risk Women Reluctant To Take Tamoxifen

Cervical Cancer Screening Can Be Done Later, Less Often

No Benefit For Cetuximab In Early-Stage Colon Cancer

NCI Cooperative Group Clinical Trials Approved

Recent Issues

Volume 52 | Issue 25 - June 26, 2026

Volume 52 | Issue 24 - June 18, 2026

Volume 52 | Issue 23 - June 12, 2026

Volume 52 | Issue 22 - June 05, 2026

Volume 52 | Issue 21 - May 29, 2026

Volume 52 | Issue 20 - May 22, 2026